Identification of new structure of indol-3-acetyl-arylsulfonohydrazide as potent α-glucosidase and α-amylase inhibitors and molecular docking

  • Muhammad Taha*
  • , Fazal Rahim
  • , Khalid zaman
  • , Syahrul Imran
  • , Khalid Mohammed Khan
  • , Syed Adnan Ali Shah
  • , Nizam Uddin
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Herein this work, indole analogs (1–16) were synthesized by treating 2-(1H-indol-3-yl)acetohydrazide with various aryl sulfonyl chloride in pyridine as solvent and screened for α-amylase and α-glucosidase inhibitory activity under positive control of standard drug acarbose (IC50 = 12.80 ± 0.10 μM /12.90 ± 0.10 μM. All analogs of the series appeared with excellent to good inhibitory activity as compared to standard drug. The inhibitory activity range for α-amylase is 0.70 ± 0.01 μM to 19.40 ± 0.40 μM, while for α-glucosidase inhibitory activity is 1.20 ± 0.10 μM to 20.40 ± 0.40 μM respectively. Most of the analogs appeared with excellent inhibitory activity, and some analogs like 5, 6, 7, 8, 9, 10,13 and 14 for both enzymes displayed many folds better inhibitory activity than standard drug acarbose. The influences of substituents on inhibitory activity were superficially resonated via structure activity relationship. Docking studies were established to confirm the binding interaction between analogs and active sites of enzymes.

Original languageEnglish
Article number140719
JournalJournal of Molecular Structure
Volume1323
DOIs
StatePublished - 25 Feb 2025

Keywords

  • Diabetics II
  • Indol-3-acetyl-arylsulfonohydrazide
  • Molecular docking

Fingerprint

Dive into the research topics of 'Identification of new structure of indol-3-acetyl-arylsulfonohydrazide as potent α-glucosidase and α-amylase inhibitors and molecular docking'. Together they form a unique fingerprint.

Cite this